4//SEC Filing
DANIELS RONALD J 4
Accession 0001470831-25-000297
CIK 0001743881other
Filed
Nov 6, 7:00 PM ET
Accepted
Nov 7, 6:03 PM ET
Size
481.9 KB
Accession
0001470831-25-000297
Insider Transaction Report
Form 4
DANIELS RONALD J
Director
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2025-11-06−61,031→ 30,523 totalExercise: $34.65Exp: 2030-02-11→ Common Stock (61,031 underlying) - Sale
Common Stock
2025-11-06$63.72/sh−61,031$3,888,999→ 16,991 total - Exercise/Conversion
Common Stock
2025-11-06$34.65/sh+61,031$2,114,724→ 78,022 total
Footnotes (2)
- [F1]Represents the weighted average sale price of the shares sold from $63.70 to $63.88 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
- [F2]The shares subject to this option vested and became exercisable in three annual installments from February 12, 2020 to February 12, 2023.
Issuer
BridgeBio Pharma, Inc.
CIK 0001743881
Entity typeother
IncorporatedOntario, Canada
Related Parties
1- filerCIK 0001164475
Filing Metadata
- Form type
- 4
- Filed
- Nov 6, 7:00 PM ET
- Accepted
- Nov 7, 6:03 PM ET
- Size
- 481.9 KB